Origins Fund

Origins Fund is a smaller investment vehicle with a visible website and LinkedIn presence but no disclosed healthcare thesis, sub-vertical focus, AI angle, stage preference, geography or check size in the source data. Without explicit positioning, founders should treat Origins as an early-stage generalist whose name suggests a focus on first-money-in or pre-seed positioning. Plausible check sizes for a firm of this profile sit in the $100K to $750K range as a participant in pre-seed and seed rounds, with limited capacity to lead competitive rounds and modest reserve capacity for follow-ons. Origins is most plausibly a fit for very early-stage digital health, healthcare IT and consumer health founders where the firm can underwrite team and idea risk rather than commercial proof points. Therapeutics, regulated devices, diagnostics and any capital-intensive healthcare play are unlikely fits at this scale. Founders raising for clinical AI products should expect to do most of the regulatory and reimbursement education themselves and should not count on Origins for hospital network introductions or scientific diligence partners. Entry is realistic via direct LinkedIn outreach to firm principals, ideally via a mutual founder or angel introduction, with a tight pitch focused on team, problem-solution clarity and capital efficiency. In a first conversation, push for fund size, lead capacity, average check, healthcare exposure in the existing portfolio, and what genuine value-add the firm offers beyond capital. Until clearer signal emerges, Origins belongs on a list-builder tier rather than a primary target.